Table 4.
Viral target | Drugs or therapy methods |
---|---|
HIV Protease inhibitors | Darunavir, Lopinavir, Ritonavir, etc. |
SARS-CoV-2 Mpro inhibitors | Ebselen, Tideglusib, Carmofur, α-ketoamides, Pelitinib, etc. |
SARS-CoV-2 PLpro inhibitors | VIR250, VIR251, GRL0617, etc. |
HCV NS3/4A protease | Grazoprevir, etc. |
HCV NS1 inhibitors | Epigallocatechine gallate, etc. |